+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

United States Active Pharmaceutical Ingredient Market, By Method of Synthesis, By Source, By Distribution Channel, By Therapeutic Application, By Form, By Molecule Type, By Potency, By Drug Type, By Region, Competition Forecast & Opportunities, 2016 - 2026

  • ID: 5292808
  • Report
  • February 2021
  • Region: United States
  • 71 pages
  • TechSci Research
The United States Active Pharmaceutical Ingredient Market Stood at USD 17.81 Billion in 2020 and is Projected to Grow at a CAGR of 9.73% to Cross USD 31.48 Billion by 2026.

FEATURED COMPANIES

  • AbbVie Inc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The United States Active Pharmaceutical Ingredient Market stood at USD17.81 billion in 2020 and is projected to grow at a CAGR of 9.73% to cross USD31.48 billion by 2026. This can be attributed to growing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, respiratory disorders, among others. This has drastically increased the patient pool thereby increasing the demand for drugs. This in turn is expected to positively influence the market growth through 2026. Additionally, increasing R&D by various biopharmaceutical companies in drug discovery is further expected to spur the market growth over the next few years. Besides this, growing importance of generics is also expected to foster the market growth in the next five years.

The United States Active Pharmaceutical Ingredient Market can be segregated based on method of synthesis, source, distribution channel, therapeutic application, form, molecule type, potency, drug type, region and company. Based on method of synthesis, the market can be split into synthetic and biological. The synthetic method of synthesis dominated the market with a share of 58.29% in 2020 on account of the easy availability of raw materials and easier process for development of active pharmaceutical ingredients. While the biological method of synthesis segment is expected to grow at a rate of 10.82% during the forecast period owing to the growing demand for vaccines, monoclonal antibodies, recombinant proteins, biosimilars, among others.

Leading players operating in the market include Teva Pharmaceutical Industries Limited, Merck & Co., Inc., Pfizer Inc., Dr. Reddy’s Laboratories Limited, Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals, Inc., GlaxoSmithKline Plc, Novartis Inc. (Sandoz), Aurobindo Pharma USA, Inc., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, AbbVie Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Sanofi-Aventis U.S. LLC and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments. For instance, in 2020, Pfizer (US) signed a multiyear agreement with Gilead Sciences Inc., to manufacture and supply Gilead’s antiviral drug (Remdesivir) for the treatment of COVID-19.

Years considered for this report:
  • Historical Years: 2016 - 2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022- 2026
Objective of the Study:
  • The primary objective of the study was to evaluate and forecast active pharmaceutical ingredient market in United States from 2021-2026.
  • To categorize the market on the basis of method of synthesis, source, distribution channel, therapeutic application, form, molecule type, potency, drug type, region and company.
  • To identify major drivers, challenges and trends in the United States Active Pharmaceutical Ingredient Market.
  • To identify the dominant region or segment in the United States Active Pharmaceutical Ingredient Market.
  • To examine competitive developments such as expansions, new product launches, mergers and acquisitions, etc., in the United States Active Pharmaceutical Ingredient Market.
  • To identify and analyze the profiles of leading players operating in the United States Active Pharmaceutical Ingredient Market.
  • To identify key sustainable strategies adopted by market players in the United States Active Pharmaceutical Ingredient Market.
To extract the data for the United States Active Pharmaceutical Ingredient Market, primary research surveys were conducted with API manufacturer and contract manufacturer companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher was able to include manufacturers that could not be identified due to the limitations of secondary research. Moreover, the publisher analyzed various end-user segments and projected a positive outlook for the United States Active Pharmaceutical Ingredient Market over the coming years.

The publisher calculated the market size of U the United States Active Pharmaceutical Ingredient Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated them by analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Active pharmaceutical ingredient manufacturers, contract manufacturers and other stakeholders
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to active pharmaceutical ingredient
The study is useful in providing answers to several critical questions that are important for the industry stakeholders, such as active pharmaceutical ingredient manufacturers, customers and policymakers. The report also provides useful insights about which market segments should be targeted over the coming years to strategize investments and capitalize on growth opportunities.

Report Scope:

In this report, the United States Active Pharmaceutical Ingredient Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Method of Synthesis:
  • Synthetic
  • Biological
Market, By Source:
  • Contract Manufacturing Organizations
  • In-house manufacturing
Market, By Distribution Channel:
  • Offline
  • Online
Market, By Therapeutic Application:
  • Cardiovascular Disease
  • Anti-diabetic
  • Oncology
  • Neurological Disorders
  • Musculoskeletal
  • Others
Market, By Form:
  • Tablets
  • Capsule
  • Injection
  • Others
Market, By Molecule Type:
  • Small
  • Large
Market, By Potency:
  • Low
  • High
Market, By Drug Type:
  • Innovator
  • Generics
Market, By Region:
  • North-East
  • Mid-West
  • West
  • South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Active Pharmaceutical Ingredient Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.

This report will be delivered within 2 business days
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on United States Active Pharmaceutical Ingredient Market

4. Executive Summary

5. Global Active Pharmaceutical Ingredient Market Outlook

6. United States Active Pharmaceutical Ingredient Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Method of Synthesis (Biological v/s. Synthetic)
6.2.2. By Source (In-house v/s Contract Manufacturing Organizations)
6.2.3. By Distribution Channel (Online v/s Offline)
6.2.4. By Therapeutic Application (Cardiovascular Disease, Anti-diabetic, Oncology, Neurological Disorders, Musculoskeletal, Others)
6.2.5. By Form (Tablet, Capsule, Injection, Others)
6.2.6. By Molecule Type (Small v/s Large)
6.2.7. By Potency (High v/s Low)
6.2.8. By Drug Type (Innovator v/s Generic)
6.2.9. By Region (West, Mid-West, North-East, South)
6.2.10. By Company
6.3. Product Market Map

7. United States Biological Active Pharmaceutical Ingredient Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Recombinant Proteins, Vaccines, Monoclonal Antibodies, Hormones, Others)
7.2.2. By Therapeutic Application
7.2.3. By Source
7.2.4. By Distribution Channel
7.2.5. By Form
7.2.6. By Molecule Type
7.2.7. By Potency
7.2.8. By Drug Type

8. United States Synthetic Active Pharmaceutical Ingredient Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Inorganic Synthetic Drugs vs. Organic Synthetic Drugs)
8.2.2. By Therapeutic Application
8.2.3. By Source
8.2.4. By Distribution Channel
8.2.5. By Form
8.2.6. By Molecule Type
8.2.7. By Potency
8.2.8. By Drug Type

9. Market Dynamics
9.1. Drivers
9.2. Challenges

10. Market Trends & Developments

11. Trade Dynamics (Top 5 APIs)
11.1. Export
11.2. Import

12. Policy & Regulatory Landscape

13. United States Economic Profile

14. Competitive Landscape (SWOT Analysis of Top 5 Players)
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Teva Pharmaceutical Industries Limited
14.2.2. Merck & Co., Inc.
14.2.3. Pfizer Inc.
14.2.4. Dr. Reddy’s Laboratories Limited
14.2.5. Lupin Pharmaceuticals, Inc.
14.2.6. Glenmark Pharmaceuticals, Inc.
14.2.7. GlaxoSmithKline Plc
14.2.8. Novartis Inc. (Sandoz)
14.2.9. Aurobindo Pharma USA, Inc.
14.2.10. Sun Pharmaceutical Industries Ltd.
14.2.11. Eli Lilly and Company
14.2.12. AbbVie Inc.
14.2.13. Bristol-Myers Squibb
14.2.14. F. Hoffmann-La Roche Ltd.
14.2.15. Sanofi-Aventis U.S. LLC

15. Strategic Recommendations

16. About the Publisher & Disclaimer

List of Figures
Figure 1: Global Active Pharmaceutical Ingredient Market Size, By Value (USD Billion), 2016-2026
Figure 2: United States Active Pharmaceutical Ingredient Market Size, By Value (USD Billion), 2016-2026
Figure 3: United States Active Pharmaceutical Ingredient Market Share, By Method of Synthesis, By Value, 2016-2026
Figure 4: United States Active Pharmaceutical Ingredient Market Share, By Source, By Value, 2016-2026
Figure 5: United States Active Pharmaceutical Ingredient Market Share, By Distribution Channel, By Value, 2016-2026
Figure 6: United States Active Pharmaceutical Ingredient Market Share, By Therapeutic Application, By Value, 2016-2026
Figure 7: United States Active Pharmaceutical Ingredient Market Share, By Form, By Value, 2016-2026
Figure 8: United States Active Pharmaceutical Ingredient Market Share, By Molecule Type, By Value, 2016-2026
Figure 9: United States Active Pharmaceutical Ingredient Market Share, By Potency, By Value, 2016-2026
Figure 10: United States Active Pharmaceutical Ingredient Market Share, By Drug Type, By Value, 2016-2026
Figure 11: United States Active Pharmaceutical Ingredient Market Share, By Region, By Value, 2016-2026
Figure 12: United States Active Pharmaceutical Ingredient Market Share, By Company, By Value, 2016-2026
Figure 13: United States Biological Active Pharmaceutical Ingredient Market Size, By Value (USD Billion), 2016-2026
Figure 14: United States Biological Active Pharmaceutical Ingredient Market Share, By Method of Synthesis, By Value, 2016-2026
Figure 15: United States Biological Active Pharmaceutical Ingredient Market Share, By Source, By Value, 2016-2026
Figure 16: United States Biological Active Pharmaceutical Ingredient Market Share, By Distribution Channel, By Value, 2016-2026
Figure 17: United States Biological Active Pharmaceutical Ingredient Market Share, By Therapeutic Application, By Value, 2016-2026
Figure 18: United States Biological Active Pharmaceutical Ingredient Market Share, By Form, By Value, 2016-2026
Figure 19: United States Biological Active Pharmaceutical Ingredient Market Share, By Molecule Type, By Value, 2016-2026
Figure 20: United States Biological Active Pharmaceutical Ingredient Market Share, By Potency, By Value, 2016-2026
Figure 21: United States Biological Active Pharmaceutical Ingredient Market Share, By Drug Type, By Value, 2016-2026
Figure 22: United States Synthetic Active Pharmaceutical Ingredient Market Size, By Value (USD Billion), 2016-2026
Figure 23: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Method of Synthesis, By Value, 2016-2026
Figure 24: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Source, By Value, 2016-2026
Figure 25: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Distribution Channel, By Value, 2016-2026
Figure 26: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Therapeutic Application, By Value, 2016-2026
Figure 27: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Form, By Value, 2016-2026
Figure 28: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Molecule Type, By Value, 2016-2026
Figure 29: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Potency, By Value, 2016-2026
Figure 30: United States Synthetic Active Pharmaceutical Ingredient Market Share, By Drug Type, By Value, 2016-2026
Note: Product cover images may vary from those shown
  • Teva Pharmaceutical Industries Limited
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Dr. Reddy’s Laboratories Limited
  • Lupin Pharmaceuticals, Inc.
  • Glenmark Pharmaceuticals, Inc.
  • GlaxoSmithKline Plc
  • Novartis Inc. (Sandoz)
  • Aurobindo Pharma USA, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • AbbVie Inc.
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd.
  • Sanofi-Aventis U.S. LLC
Note: Product cover images may vary from those shown
Adroll
adroll